SHINRY(SZ:300745)2022-04-26 16:00Revenue and Profit - The company's revenue for Q1 2022 was CNY 301,552,882.64, representing a 50.60% increase compared to CNY 200,234,692.42 in the same period last year[4] - Net profit attributable to shareholders was CNY 7,059,509.08, an increase of 82.25% from CNY 3,873,467.50 year-on-year[4] - The net profit for Q1 2022 reached ¥6.96 million, representing a growth of 79.81% from ¥3.87 million in the previous year[9] - The total profit for the period was ¥3.66 million, a significant increase of 296.27% compared to ¥923.55 thousand in the same quarter last year[9] - The total profit before tax was CNY 3,659,767.15, compared to CNY 923,548.21 in the previous year, showing a substantial increase[21] Cash Flow - Cash flow from operating activities was negative at CNY -75,498,473.45, worsening by 100.07% compared to CNY -37,736,539.21 in the previous year[4] - Cash received from operating activities rose to ¥264.14 million, a 139.94% increase from ¥110.08 million in the previous year, driven by increased collections[9] - The net cash flow from operating activities was negative at CNY -75,498,473.45, worsening from CNY -37,736,539.21 year-over-year[25] - The company incurred a total investment cash outflow of CNY 201,711,159.86, compared to CNY 123,805,160.25 in the previous year, reflecting increased investment activities[25] Assets and Liabilities - The company's total assets increased by 6.89% to CNY 2,238,718,961.83 from CNY 2,094,478,178.34 at the end of the previous year[4] - Total assets as of the end of Q1 2022 were CNY 2,238,718,961.83, up from CNY 2,094,478,178.34 at the beginning of the year, reflecting a growth of 6.9%[18] - Total liabilities increased to CNY 1,058,221,552.42 from CNY 938,774,517.41, representing a rise of 12.8%[17] - The company's equity attributable to shareholders reached CNY 1,174,392,195.40, an increase from CNY 1,155,703,660.93, showing a growth of 1.6%[18] Research and Development - The company increased its development expenditures by 35.51%, totaling CNY 17,087,518.34, reflecting a focus on R&D[8] - Research and development expenses increased by 41.29% to ¥22.20 million, up from ¥15.71 million, primarily due to increased personnel costs and depreciation[9] - Research and development expenses amounted to CNY 22,203,280.77, which is a 41.2% increase from CNY 15,714,915.59 in the previous year[19] Expenses - Total operating costs for Q1 2022 were CNY 306,559,284.70, up from CNY 200,996,235.78, reflecting a year-over-year increase of 52.5%[19] - The financial expenses increased by 44.84% to ¥3.23 million, primarily due to increased borrowing interest[9] - The company experienced a significant increase in sales expenses, which rose by 105.03% to ¥9.88 million, attributed to product quality assurance and personnel salary increases[9] Other Financial Metrics - The weighted average return on equity was 0.60%, up from 0.47% in the same period last year[4] - Basic and diluted earnings per share were both CNY 0.06, compared to CNY 0.03 in the same quarter last year, indicating a 100% increase[22] - The company reported a total comprehensive income of CNY 7,762,106.06 for the first quarter, up from CNY 3,873,467.50 in the previous year[22] - The company reported a significant increase in trade receivables by 123.27%, reaching CNY 51,668,996.56 due to increased revenue[8] - The company’s contract liabilities surged by 2551.80% to CNY 30,973,086.14, primarily due to advance payments received[8]